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PURPOSE. Diabetic cataract is one of the major eye complications of diabetes. It was reported
that cataract occurs two to five times more frequently in patients with diabetes compared
with those with no diabetes. The purpose of this study was to identify genetic contributors of
diabetic cataract based on a genome-wide association approach using a well-defined Scottish
diabetic cohort.
METHODS. We adapted linked e-health records to define diabetic cataract. A diabetic cataract
case in this study was defined as a type 2 diabetic patient who has ever been recorded in the
linked e-health records to have cataracts in both eyes or who had previous cataract extraction
surgeries in at least one eye. A control in this study was defined as a type 2 diabetic individual
who has never been diagnosed as cataract in the linked e-health records and had no history of
cataract surgeries. A standard genome-wide association approach was applied.
RESULTS. Overall, we have 2341 diabetic cataract cases and 2878 controls in the genetics of
diabetes audit and research in Tayside Scotland (GoDARTS) dataset. We found that the P value
of rs2283290 in the CACNA1C gene was 8.81 3 1010, which has reached genome-wide
significance. We also identified that the blood calcium level was statistically different between
diabetic cataract cases and controls.
CONCLUSIONS. We identified supporting evidence that CACNA1C gene is associated with
diabetic cataract. The role of calcium in the cataractogenesis needs to be reevaluated in future
studies.
Keywords: genome-wide association study, cataract, diabetes, genetics
Cataract is defined as a loss of normal transparency of thecrystalline lens in the eye due to opacification or optical
dysfunction.1 It affects light transmission and results in a
deteriorated vision.1 According to the visual impairment data
reported by the World Health Organization in 2012, cataract is
the leading cause of global blindness, accounting for 51% of the
overall cases, far higher than blindness caused by glaucoma
(8%) and by age-related macular degeneration (5%).2 In addition
to being a major ocular disorder, cataract also puts heavy
economic burdens on health care systems. For example, the
total direct medical cost of cataract was $6.8 billion in 2004 in
the USA, representing 42% of the total direct medical cost of all
visual disorders in that year.3 Cataract is also associated with
many ophthalmic and general health conditions such as myopia
and a high rate of falling.4,5
Diabetic cataract is one of the major eye complications of
diabetes. It was reported that cataract occurs two to five times
more frequently in patients with diabetes compared with
nondiabetic populations.6,7 Around one in four of the late onset
diabetic patients will undergo a cataract surgery in a 10-year
interval.7 Multiple epidemiological studies have suggested risk
factors for diabetic cataract such as age, sex, body mass index
(BMI), duration of diabetes, educational level, smoking history,
macroalbuminuria, HbA1c, and hemoglobin.8,9 Identifying
potential risk factors of diabetic cataract can help in the
generation of therapeutic interventions and supplementary
treatment methods and ease the disease burden from an
economic and public health perspective.10 The genetic studies
of cataract have been mainly focused on congenital cataract or
cataract caused by a single mutation and around 30 loci have
been identified so far.11 However, these loci or genes are less
likely to be relevant to diabetic cataract since diabetic cataract
is normally considered as a complex disorder, affected by both
genetic and environmental factors like other diabetic compli-
cations such as diabetic neuropathic pain.12,13 Lin et al.14
proposed 15 loci associated with diabetic cataract across the
genome in the Chinese population through a small scale
genome-wide association study (GWAS). These loci contain the
candidate genes PPARD, CCDC102A, GBA3, NEDD9, GABRR1/
2, RPS6KA2, HSPA8P8, TAC1, GALNTL1, and KIAA1671,
which are either involved with the mechanisms of regulating
blood sugar or the formation of cataract.14 Understanding the
genetic factors associated with diabetic cataract would help to
identify the underlying mechanisms and potentially identify
molecular targets for pharmacological research.
The purpose of this study was to identify genetic
contributors of diabetic cataract based on a genome-wide
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association approach using a well-defined Scottish diabetic
cohort.
METHODS
Participants
The genetics of diabetes audit and research in Tayside Scotland
(GoDARTS) project was originally created to identify genetic
factors for diabetes and its complications. All participants
complete a lifestyle questionnaire, undergo a baseline clinical
examination, and provide their biological samples (blood and
urine). In addition, they allow researchers to use their health
information and their biological samples for research purposes
and give permissions to link their personal information
anonymously to their national health service (NHS) medical
records. The medical records include their prescribing history,
general practice clinic visits, hospital admissions, and outpa-
tient appointments. Furthermore, their personal information is
anonymously linked with the Scottish Care Information-
Diabetes Collaboration (SCI-DC) database, which is an elec-
tronic health record system designed to keep track of local
diabetic patients and help health professionals to provide
better care in Scotland. Written informed consent was
obtained from all participants. Further information about the
GoDARTS project is available in the public domain at http://
diabetesgenetics.dundee.ac.uk/. The research followed the
tenets of the Declaration of Helsinki. The ethics approval has
been granted by Tayside Committee on Medical Research
Ethics (REC reference 053/04).
The GoDARTS project has recruited 9439 diabetic patients
so far, among which 6927 were already genotyped by DNA
chips. All GoDARTS participants’ health information was
anonymously linked with their NHS and SCI-DC medical
records from their enrollment until June 2011.
Definitions of Diabetic Cataract Cases and Controls
A diabetic cataract case in this study was defined as a type 2
diabetic patient who had ever been recorded in the linked e-
health records as having cataracts in both eyes or who had
previous cataract extraction surgeries in at least one eye. In the
linked e-health records, there is no indication of the subtypes
of cataract such as cortical cataract, nuclear cataract, and
posterior subcapsular cataract as well as the severity of
cataract. The diagnosis of cataract is mainly made by clinicians
in the annual national retinal screen service.
A control in this study was defined as a type 2 diabetic
individual who has never been diagnosed as cataract in the
linked e-health records and had no history of cataract surgeries.
No other criteria (such as trauma and infection) were
considered when defining cases and controls.
Genotyping and Quality Control
The project GoDARTS adapted two types of DNA chips to
genotype its diabetic individuals. The Affymetrix SNP 6.0 chips
(used on 3673 subjects; Affymetrix, Santa Clara, CA, USA) were
funded by the Wellcome Trust Case Control Consortium 2
(WTCCC2) project15; the Illumina chips (used on 3254
subjects; OmniExpress BeadChip kit; Illumina, Inc., San Diego,
CA, USA) were funded by the surrogate markers for micro- and
macrovascular hard endpoints for innovative diabetes tools
(SUMMIT) project.16 Genotype data quality controls were
based on the standard protocols that were established for the
WTCCC2 studies15 and the SUMMIT studies.16
Statistical Analysis
Software SHAPEIT and IMPUTE2 were used to impute non-
directly genotyped single nucleotide polymorphisms (SNP)
with reference files from the 1000 genomes phase I datasets
(both directly genotyped SNPs and reference files were based
on genome assembly National Center for Biotechnology
Information b37).17,18 To filter out poorly imputed SNPs, a r2
< 0.3 is applied as it is the lower threshold value
recommended by IMPUTE2 and we wanted to maximize the
number of SNPs for further analysis.
The primary data manipulation software was PLINK and
routine quality control steps were frequently applied during
data analyses (e.g., removing SNPs with less than 95%
genotyping call rate, SNPs with minor allele frequency less
than 1%, SNPs that failed Hardy–Weinberg tests P < 0.000001
[based on control samples only], and removing individuals
with more than 5% genotype data missing).19 Single nucleotide
polymorphisms on sex chromosomes and mitochondrion were
excluded. Multidimensional scaling analysis integrated in
PLINK was used to detect population stratification. A lambda
value was calculated to indicate the level of stratification. The
lambda value should be very close to 1 indicating a minimum
ancestry mixture. Samples with pi-hat > 0.125 were discarded
due to relatedness. A logistic regression test with multiple
covariates was applied to generate P values for SNP associa-
tions. A value of P < 53 108 is considered to be significant.
Other GWAS-related software used in our study were:
SNPnexus for SNP functional annotation,20 HaploView for
generating Manhattan plots and linkage disequilibrium (LD)
blocks,21 and SNPEVG for generating corresponding quantile-
quantile (q-q) plot to evaluate differences between cases and
controls caused by potential confounders (different genotyping
laboratories, different DNA extraction methods, etc.).22 Means
of age, BMI, cholesterol, triglycerides, high-density lipoprotein
(HDL), low-density lipoprotein (LDL), and HbA1c were
compared between cases and controls using independent t-
test (SPSS 22; IBM Corp., Armonk, NY, USA). Sex difference
was compared using a v2 test. Blood calcium level was
compared later using an independent t-test. The whole
workflow was shown in Supplementary Figure S1.
RESULTS
In this general diabetic cohort, we identified 2501 type 2
diabetic patients with cataract and 3032 controls with no
cataract according to the linked e-health records after
removing type 1 diabetic patients and patients with no genetic
data. Then, after filtering out related samples and outlier
samples detected by population stratification analyses, we had
2341 diabetic cataract cases (males ¼ 1249, females ¼ 1092)
and 2878 controls (males ¼ 1655, females ¼ 1223). The
prevalence of diabetic cataract in our cohort was 44.9%. We
compared the means of sex, age, BMI, cholesterol, triglycer-
ides, HDL, LDL, HbA1c between cases and controls. There
were statistical differences in sex, age, BMI, HDL, LDL, HbA1c
between cases and controls while there was no statistical
difference in cholesterol and triglycerides (Table 1).
Affymetrix SNP6.0 chips contain 704,847 directly geno-
typed and quality-controlled SNPs and Illumina OmniExpress
chips contain 601,394 directly genotyped and quality-con-
trolled SNPs. Altogether, 6,398,685 genotyped and imputed
SNPs were available for further analysis, after routine quality
control of genotyping and imputation. The lambda value,
which indicates the level of population stratification, was 1.06
and therefore no further adjustments for population stratifica-
tion was needed. We then performed logistic regression tests
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on all SNPs, with age, sex, BMI, HDL, LDL, and HbA1c as
covariates. We identified rs2283290 in the CACNA1C gene with
a P value of 8.81 3 1010 and an odds ratio (OR) of 0.72 (A
allele, 95% confidence interval: 0.66–0.80; Fig.). We calculated
the correlation between rs2283290 and 10 upstream and 10
downstream SNPs using PLINK and found that it was not in LD
(R2 > 0.8) with any of its nearby SNPs (Supplementary Fig. S2).
We also downloaded the linkage information of this SNP from
HapMap and found the SNP was not in LD with its nearby SNPs
as well (Supplementary Fig. S3). The plot q-q of the association
results was shown in the Supplementary Figure S4.
We extracted the baseline blood calcium values of cases and
controls from the linked e-health records (only 4222 individ-
uals have those values recorded). We found that there was a
statistical difference of the blood calcium levels between
diabetic cataract cases and controls in both men and women (P
¼ 0.001; Table 2).
DISCUSSION
We performed a GWAS on diabetic cataract using a Scottish
diabetic cohort based on phenotype information from linked e-
health records and genetic information from DNA chips. We
found that CACNA1C gene may be involved with diabetic
cataract.
All diabetic patients in Scotland are invited to have retinal
screening annually. During the screening, clinicians determine
whether patients have cataracts or not, along with the
diagnosis of diabetic retinopathy. However, in the case of a
diagnosis of a cataract, the specific subtype of the cataract or
the severity of the cataract is not reported. In fact, cataract
appears more often in a mixed format—a combination of
nuclear cataract, cortical cataract or posterior subcapsular
cataract—than a single entity in clinical settings.23 It was
reported that around one in three cataracts are a mixed type in
a diabetic population.9 Therefore, the phenotype used in our
study is ‘‘any cataract,’’ including mixed cataracts and any
subtypes of cataracts. The prevalence of diabetic cataract in
our cohort is 44.9%, which is matched with the prevalence of
47.9% for diabetic cataract in an Indian diabetic population.9 In
principle, using a specific subtype of cataracts will have a
higher ability to identify relative genes for genetic studies while
in reality, these advantages normally are offset by reduced
sample size and correspondingly reduced study power. In this
study, using the CaTS power calculator, we had 80% power
based on 2341 cases and 2878 controls, assuming a minor
disease allele frequency of 0.15, a genotypic relative risk of
1.21, a prevalence of diabetic cataract in the diabetic
population of 0.45, and the significance level of 53 108.24
We identified that the smallest P value was 8.81 3 1010
with an OR of 0.72 for rs2283290 in the CACNA1C gene, which
reached GWAS significance (P < 5 3 108). It was a sporadic
SNP with no supporting SNPs in the plot. The linkage
disequilibrium analysis of the cohort revealed that this SNP
had small R2 values (indicating levels of LD) with its nearby
SNPs (10 upstream and 10 downstream SNPs). This finding was
matched with the HapMap Caucasian dataset, which also
shows that rs2283290 and its nearby SNPs are not in LD,
indicating that the significance is not caused by a genotyping
error (Supplementary Fig. S3). The closest SNP in LD with
rs2283290 is rs2239032 (10 kb away, R2¼0.97) in the HapMap
TABLE 1. Clinical Characteristic of Diabetic Cataract Cases and Controls
Covariates Cases Controls P
Sex, male:female 1249:1092 1655:1223 0.0027
Age, y (range) 67.92 6 9.89 (31–93) 65.97 6 10.38 (28–95) <0.001
BMI, kg/m2 31.02 6 5.57 31.52 6 5.89 0.002
Cholesterol, mmol/L 4.36 6 0.86 4.39 6 0.92 0.149
Triglycerides, mmol/L 2.18 6 1.21 2.23 6 1.44 0.196
HDL, mmol/L 1.38 6 0.38 1.34 6 0.36 <0.001
LDL, mmol/L 2.04 6 0.68 2.10 6 0.73 0.004
HbA1c, % 7.63 6 1.40 7.30 6 1.32 <0.001
A v2 test was used to test the difference of sex frequency between cases and controls and an independent t-test was used for other covariates.
Covariates were presented as mean 6 standard deviation.
FIGURE. The Manhattan plot of the GWAS on diabetic cataract (2341 cases and 2878 controls) SNPs with P < 0.01 were not included. The red line
represents a P value of 53 108 in the plot.
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dataset, but the R2 score is 0.70 between the two SNPs in our
GWAS dataset. This can be due to the population difference
since we used a diabetic population while HapMap used a
general Caucasian population. The imputation score of this
SNP in our dataset is 0.970 (imputed in Affymetrix chips only
since the SNP is directly genotyped in Illumina chips),
indicating a good imputation result. The CACNA1C gene
encodes a protein called the alpha-1 subunit of a voltage-
dependent, dependent L-type calcium channel (also known as
CaV1.2). The calcium channel CaV1.2 is expressed and
distributed in the epithelium and cortical fiber cells in the
mouse lens, especially in the short arms of the hexagonal lens
fibers.25 The channel CaV1.2 influences different cellular
responses as it relates to the regulation of intracellular
calcium.26 Inhibition of the L-type calcium channel with
felodipine or nifedipine has been reported to induce progres-
sive cortical cataract formation and be associated with
decreased lens weight in ex vivo mouse lenses.25 In addition,
L-type calcium channel inhibitors have been reported to delay
formation of diabetic cataract in rodents.27 Proliferation of
human lens epithelial cells is also inhibited by blocking of
calcium channels.28 Researchers have confirmed there was a
more than a 23-fold increase in total lens calcium with
cataract.29 Calcium homeostasis has been confirmed to be
impaired in lens from diabetic rats and diabetic rabbits.30,31 In
this study, we could not measure calcium in the lens, but we
found that the total blood calcium was statistically different
between diabetic cataract cases and controls both in males and
in females. The result represented statistical significance
although it requires further evidence to discover if there is a
physiological reason behind it. Genetic variants in the
CACNA1C gene have been reported in multiple diseases such
as arrhythmia, bipolar disorder, and schizophrenia.32–34 Fur-
ther studies are needed to explore the functional role of
CACNA1C in diabetic cataract.
At the moment, the mechanism of diabetic cataract is not
clear. Some evidence has supported the polyol pathway
mechanism, which produces overloaded sorbitol from glucose
first and then the overloaded sorbitol increases the osmotic
stress in the lens fiber leading to its swelling and rupture.35,36
The pathway was widely indicated for the microvascular
damage of the diabetic complications such as diabetic
retinopathy.37 However, the result of a large clinical trial on
this pathway is negative for diabetic retinopathy.38 This
indicates the involvement of other possible mechanisms such
as pathways including calcium. As we identified in this study,
the blood calcium level is statistically different between
diabetic cataract cases and controls in men and women.
Combining the fact that the calcium level is significantly
elevated in the lens during cataract, calcium might have a
greater role in the cataractogenesis than we expected.
It is also very challenging to differentiate age-related
cataract from diabetic cataract since a type 2 diabetic
population is normally an elder population as well. The
development of cataract in a diabetic patient could be partly
due to the aging process. At the moment, we do not know the
interaction between the aging process and diabetic contribu-
tion in terms of cataractogenesis. Do they work independently,
or do they accelerate each other’s role in cataractogenesis?
Therefore, a wiser phenotyping strategy should be established
to identify diabetic cataract in an elder diabetic population.39
We also extracted our results of the SNPs which were
reported by other GWAS on cataract such as Lin et al.40
(diabetic cataract), Liao et al.11 (age-related cataract), and
Ritchie et al.41 (age-related cataract; Supplementary Table S1).
The statistical P values of these SNPs in our study were not
small enough to merit further investigation.
In conclusion, we identified that CACNA1C gene is
associated with diabetic cataract in a Scottish diabetic cohort
using a GWAS approach. We also reported that the blood
calcium level is significantly different between diabetic cataract
cases and controls indicating the potential role of calcium in
the cataractogenesis.
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